Landauer Inc

Landauer — Q1 FY2013 Earnings Presentation

21 slides from Landauer's earnings presentation, Feb 12, 2013

  1. Slide 1: Fiscal 2013 First Quarter Results

    LANDAUER, INC. Fiscal 2013 First Quarter Results February 12, 2013

  2. Slide 2: Safe Harbor Statement

    2 Safe Harbor Statement Some of the information shared here (including, in particular, the section titled “Fiscal 2013 Outlook”) constitutes forward - looking statements that are based on assumptions and involve certain risks and uncertainties . These include the following, without limitation : assu

  3. Slide 3: Fiscal 2013 First Quarter Highlights

    3  Consolidated revenue $36.7 million, flat to prior year: - Acquisitions annualized $2.5 million: » Medical Products $2.2 million » Medical Physics $0.3 million  Consolidated gross profit $20.1 million, $1.6 million below prior year: - Additional IT Platform depreciation expense $0.5 million, and

  4. Slide 4: Landauer Strategy Overview

    Value Creation Deliver Upside Growth 1. Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion Optimize the Core Competitive Growth  New Management/ Structure • Chief Financial Officer Q1’12 • Radiation Measurement Segment Q3‘12

  5. Slide 5: The Radiation Safety Continuum

    Therapeutic / Diagnostic Accessories Information Imaging Physics Therapy Physics Patient Monitoring Occupational Monitoring Consulting Strategic Expansion Existing Services with Penetration Opportunities (1) Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Fac

  6. Slide 6: Addressable Markets

    Addressable Markets 2005 2010 2011 2012 Occupational Monitoring Radon Military Emergency Response Forensics Dose Reconstruction Patient Dose Consumer Radiation Radiation Markers Radiation Shielding Occupation Monitoring Radiation Instruments Radiation Measurements Patient Dose Information Management

  7. Slide 7: Competitive Growth: Expanding Global Military Relationships

    7 Competitive Growth Expanding Global Military Relationships  The U.S. military has now issued orders in excess of $20 million to upgrade its tactical dosimetry capabilities, and dosimetry laboratory • Radwatch system shipments in Q1 ‘13 x $1.7 million primarily to the United States Military • FY 2

  8. Slide 8: Military and Emergency Response Market Opportunity

    Military and Emergency Response Market Opportunity  Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets  The U.S. military has now issued orders in excess of $20 million to upgrade its tactical dosimetry capabilities, and d

  9. Slide 9: Network of Activities - Synchronization

    9 Network of Activities - Synchronization

  10. Slide 10: Strategic Expansion: Medical Physics

    10 Strategic Expansion Medical Physics  Medical Physics produced $7.6 million in revenues for first fiscal quarter 2013  Ongoing efforts to increase episodic premium services, leveraging a relatively fixed cost structure  Continued focus on driving growth and profitability translated to another q

  11. Slide 11: Radiation Safety is becoming more complex

    Radiation Safety is becoming more complex Assessment Remediation Ongoing Execution Control & Monitor 11 Advanced imaging and treatment choices, healthcare consolidation and tougher regulations and standards are raising the bar for radiation safety

  12. Slide 12: Nationally Recognized Top Health System

    Nationally Recognized Top 15 Health System 12 • Incremental Opportunity $2M • Strategy: - Verifii™Quality Dashboards - Continued CEO Executive Sponsor Landauer Medical Physics Leadership and Oversight Across System: Physicist and Oncologist tied at the hip

  13. Slide 13: Strategic Expansion: Medical Products

    13 Strategic Expansion Medical Products  Medical Products segment generated revenues of $2.7 million for first fiscal quarter 2013  Operating income was $0.7 million with an operating margin 24.9 percent for first fiscal quarter 2013  Experienced medical device CEO recruited in Q1 FY 2013

  14. Slide 14: IZI Medical Market Map

    IZI Medical Market Map Spherz Radiation Therapy 14

  15. Slide 15: Optimize the Core: Systems Initiative Update

    15 Optimize the Core Systems Initiative Update  Went “Live” in July 2012  Full order to cash functionality; Successful Full Year financial close September 2012  Measured approach to the phased implementation paid dividends – Minimized the risk of any disruptions to customers or on Landauer daily

  16. Slide 16: LDR IT Evolution: 2006 - 2012

    LDR IT Evolution: 2006 - 2012 Applications (since 2007) Infrastructure (since 2007) • Customer Records - o ver 500M records migrated from IBM legacy system to new IT System platform • Data Center Co - location Strategy – implemented in FY12. Disaster Recovery / Risk Mitigation: total investment to d

  17. Slide 17: FY 2013 Outlook

    FY 2013 Outlook 17 Fiscal 2013 Outlook ▪ Expected Revenue $164 to $168 million, which includes a full fiscal year of contributions from the IZI Medical Products acquisition, versus 10.5 months in fiscal 2012 ▪ Adjusted EBITDA of $55 to $58 million ▪ Net Income of $21 to $23 million FY 2013 Outlook v

  18. Slide 18: FY 2013 Outlook vs. FY 2012 Actual

    FY 2013 Outlook vs. FY 2012 Actual New IT Platform Enhancement Expenses – Depreciation/ Steady State/ Customer Service / Implementation/ Stabilization expenses: • Total FY 2013 vs. FY 2012 $4.0 million increased expense over prior year (previously, $5.6 million): – Depreciation, additional $2.4 mill

  19. Slide 19: FY 2013 Outlook vs. FY 2012 Actual: Stock Based Compensation

    FY 2013 Outlook vs. FY 2012 Actual Non - Cash Stock Based Compensation Nov.’13 Revised Guidance Guidance – FY 2013 Forecast $3.6M $3.3M – FY 2012 Actual $2.4M – Delta $1.2M $0.9M 19

  20. Slide 20: Dividend Policy

    20 Dividend Policy Dividend Policy • Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the first quarter of fiscal 2013 – This represents an annual rate of $2.20 per share, consistent with fiscal 2012 levels – For the first fiscal quarter, the dividend was paid on

  21. Slide 21: Questions?

    Questions? Fiscal 2013 First Quarter Results February 12th, 2013

Landauer — Q1 FY2013 Earnings Presentation on 6ix